日本儿童急性淋巴细胞白血病全基因组关联研究显示NUDT15遗传变异与6-巯基嘌呤耐受性相关
该全基因组关联研究纳入224例日本急性淋巴细胞白血病儿童(复制阶段55例),评估维持治疗初始168天平均6-巯基嘌呤剂量与单核苷酸多态性的关联。结果显示13q14.2区域NUDT15变异rs116855232与6-MP剂量显著相关(β=-10.99,p=3.7×10⁻¹³)并获复制,AFF3和CHST11变异关联未获复制。
要点
- NUDT15 rs116855232与6-MP平均剂量显著相关(β=-10.99,p=3.7×10⁻¹³),获全基因组复制。
- AFF3 rs75364948(p=2.05×10⁻⁶)和CHST11 rs1148407(p=2.09×10⁻⁶)关联未复制。
- MTHFR rs1801133与较高平均6-MP剂量相关(p=0.045),FOLH1 rs12574928在候选区域分析中相关(padjust=0.013)。
核心结论
- 本研究提供强证据表明NUDT15 rs116855232是日本儿童中与6-MP可耐受剂量主要相关的遗传因素。
研究设计与样本
- 全基因组关联研究,纳入224例既往入组东京儿童癌症研究组临床研究的日本ALL儿童,并在55例中进行复制。
- 评估全基因组单核苷酸多态性基因型与维持治疗初始168天平均6-MP剂量的关联。
主要发现
- 五个基因编码区域观察到可能关联,其中仅13q14.2区域变异在全基因组水平显著并获复制(rs116855232,NUDT15,β=-10.99,p=3.7×10⁻¹³)。
- AFF3 rs75364948(p=2.05×10⁻⁶)和CHST11 rs1148407(p=2.09×10⁻⁶)变异关联未获复制,可能因样本数少。
- 既往报道的MTHFR候选SNP rs1801133与较高平均6-MP剂量相关(p=0.045)。
- 候选区域分析中FOLH1 rs12574928相关(padjust=0.013)。
局限性
- AFF3和CHST11变异关联未获复制,可能因样本数少。
- 已知NUDT15和TPMT变异不能完全预测亚洲ALL儿童6-MP可耐受剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inherited genetic variation is associated with 6-mercaptopurine (6-MP) dose reduction and frequent toxicities induced by 6-MP. However, the tolerable dose for 6-MP is not fully predicted by the known variation in NUDT15 and TPMT among Asian children with acute lymphoblastic leukaemia (ALL). We performed a genome-wide association study (GWAS) related to 6-MP dose among Japanese children with ALL. This GWAS comprised 224 patients previously enrolled in Tokyo Children's Cancer Study Group clinical studies with replication attempted in 55 patients. Genome-wide single nucleotide polymorphism (SNP) genotypes were evaluated for association with average 6-MP dose during the initial 168 days of maintenance therapy. Possible associations were observed across five gene-coding regions, among which only variants at 13q14.2 were significant and replicated genome-wide (rs116855232, NUDT15, β = -10.99, p = 3.7 × 10-13 ). Notable findings were observed for variants in AFF3 (rs75364948, p = 2.05 × 10-6 ) and CHST11 (rs1148407, p = 2.09 × 10-6 ), but were not replicated possibly due to small numbers. A previously reported candidate SNP in MTHFR was associated with higher average 6-MP dose (rs1801133, p = 0.045), and FOLH1 (rs12574928) was associated in an evaluation of candidate regions (padjust = 0.013). This study provides strong evidence that rs116855232 in NUDT15 is the genetic factor predominantly associated with 6-MP tolerable dose in children in Japan.
引用
- Tanaka Y, Urayama KY, Mori M, et al. Prominence of NUDT15 genetic variation associated with 6-mercaptopurine tolerance in a genome-wide association study of Japanese children with acute lymphoblastic leukaemia. Br J Haematol. 2022. PMID: 35961941. doi:10.1111/bjh.18405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。